CN105194407A - Traditional Chinese medicine capsules for treatment of verbal ambiguity of phlegm-dampness collateral-blocking type cerebral infarction patients and preparation method thereof - Google Patents
Traditional Chinese medicine capsules for treatment of verbal ambiguity of phlegm-dampness collateral-blocking type cerebral infarction patients and preparation method thereof Download PDFInfo
- Publication number
- CN105194407A CN105194407A CN201510711669.6A CN201510711669A CN105194407A CN 105194407 A CN105194407 A CN 105194407A CN 201510711669 A CN201510711669 A CN 201510711669A CN 105194407 A CN105194407 A CN 105194407A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- herba
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses traditional Chinese medicine capsules for treatment of verbal ambiguity of phlegm-dampness collateral-blocking type cerebral infarction patients. The traditional Chinese medicine capsules are prepared from the following traditional Chinese medicine raw materials in parts by weight: 10 parts of herba pyrolae, 6 parts of stink bug, 10 parts of salvia miltiorrhiza, 7 parts of a notoginseng powder, 12 parts of rhizoma phragmitis, 7 parts of calcined concha arcae, 12 parts of sandalwood, 12 parts of cuttlebone, 10 parts of caulis dendrobii, 15 parts of betel nut, 15 parts of rhizoma anemarrhenae, 10 parts of endothelium corneum gigeriae galli, 8 parts of codonopsis pilosula, 15 parts of loofah sponge, 10 parts of radix dipsaci, 10 parts of semen cuscutae, 10 parts of coffonrose hibiscus leaf, 10 parts of honeycomb, 6 parts of amber, 8 parts of white atractylodes rhizome, 5 parts of szechwan chinaberry fruit, 7 parts of inula flower, 10 parts of cortex phellodendri, 12 parts of lily magnolia, 6 parts of fructus xanthii, 6 parts of herba violae, 12 parts of fingered citron, 15 parts of herba cepbalanoplosis segeti, 5 parts of eucommia ulmoides, 8 parts of radix scrophulariae, 10 parts of fructus evodiae, 9 parts of couch grass root, 9 parts of cinnamomum cassia presel, 10 parts of radix bupleuri, 8 parts of apricot kernel, and 6 parts of herba epimedii. Through dialectical compatibility, the traditional Chinese medicine raw materials together play the efficacies of clearing away heat and toxic materials, removing dampness to reduce phlegm, clearing and activating the channels and collaterals, and purging fire to relieve restlessness, and the traditional Chinese medicine capsules have significant effect on verbal ambiguity of the phlegm-dampness collateral-blocking type cerebral infarction patients, and can simultaneously treat principal and subordinate symptoms .
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of cerebral infarction, specifically relate to one and treat the unclean Chinese medicine capsules of phlegm-damp resistance network type Patients with Cerebral Infarction speech, and the preparation method of this Chinese medicine capsules, belong to the field of Chinese medicines.
Background technology
Cerebral infarction, also known as cerebral infarction, refers to that local brain tissue is because of disturbance of blood circulation, ischemia, anoxia and the softening necrosis occurred.Mainly there is atherosis and thrombosis due to the tremulous pulse supplying brain blood in cerebral infarction, makes luminal stenosis even inaccessible, cause focal acute brain blood supply insufficiency and fall ill.
We often run into the unclean situation of Patients with Cerebral Infarction speech clinically, conventional therapy weak effect, and the cycle is long, cause huge burden to minimal invasive treatment, also result in heavy strike psychologically.
Summary of the invention
One is the object of the present invention is to provide to treat unclean Chinese medicine capsules of phlegm-damp resistance network type Patients with Cerebral Infarction speech and preparation method thereof.
The technology used in the present invention solution is:
One treats the unclean Chinese medicine capsules of phlegm-damp resistance network type Patients with Cerebral Infarction speech, it is made by the raw material of Chinese medicine of following weight: Herba Pyrolae 10, Aspongopus 6, Radix Salviae Miltiorrhizae 10, Radix Notoginseng powder 7, Rhizoma Phragmitis 12, Concha Arcae (calcined) 7, Lignum Santali Albi 12, Endoconcha Sepiae 12, Herba Dendrobii 10, Semen Arecae 15, the Rhizoma Anemarrhenae 15, Endothelium Corneum Gigeriae Galli 10, Radix Codonopsis 8, Retinervus Luffae Fructus 15, Radix Dipsaci 10, Semen Cuscutae 10, Folium Hibisci Mutabilis 10, Nidus Vespae 10, succinum 6, the Rhizoma Atractylodis Macrocephalae 8, Fructus Toosendan 5, Flos Inulae 7, Cortex Phellodendri 10, Flos Magnoliae 12, Fructus Xanthii 6, Herba Violae 6, Fructus Citri Sarcodactylis 12, Herba Cirsii 15, the Cortex Eucommiae 5, Radix Scrophulariae 8, Fructus Evodiae 10, Rhizoma Imperatae 9, Cortex Cinnamomi 9, Radix Bupleuri 10, Semen Armeniacae Amarum 8, Herba Epimedii 6.
The preparation method of above-mentioned Chinese medicine capsules, comprises the following steps:
A takes Herba Pyrolae, Aspongopus, Radix Salviae Miltiorrhizae, Radix Notoginseng powder, Rhizoma Phragmitis, Concha Arcae (calcined), Lignum Santali Albi, Endoconcha Sepiae, Herba Dendrobii, Semen Arecae, the Rhizoma Anemarrhenae, Endothelium Corneum Gigeriae Galli, Radix Codonopsis, Retinervus Luffae Fructus, Radix Dipsaci, Semen Cuscutae, Folium Hibisci Mutabilis, Nidus Vespae, succinum, the Rhizoma Atractylodis Macrocephalae, Fructus Toosendan, Flos Inulae, Cortex Phellodendri, Flos Magnoliae, Fructus Xanthii, Herba Violae, Fructus Citri Sarcodactylis, Herba Cirsii, the Cortex Eucommiae, Radix Scrophulariae, Fructus Evodiae, Rhizoma Imperatae, Cortex Cinnamomi, Radix Bupleuri, Semen Armeniacae Amarum, Herba Epimedii totally 36 taste raw material of Chinese medicine respectively according to above-mentioned weight proportion;
B chooses the Aspongopus after weighing, Radix Notoginseng powder, Concha Arcae (calcined), Endoconcha Sepiae, succinum, is ground into 120-200 order fine powder respectively, sieves, mixes, obtain standby material one;
C is by remaining 31 taste raw material of Chinese medicine mixing, and add 8 times of water gagings, soak 2 hours, heating decoction 1.5 hours, filters to obtain decoction liquor one and residue; Residue adds 8 times of water gagings again, and heating decoction 1 hour, filters to obtain decoction liquor two; Merge decoction liquor one and decoction liquor two, filter, be under the condition of 60 DEG C in temperature, concentrating under reduced pressure becomes relative density to be the thick paste of 1.2-1.3, cold drying, is ground into 120-200 order fine powder, obtains standby material two;
Standby material one is mixed homogeneously with standby material two by d, dries, sterilization, then is ground into 200 order fineness, incapsulates, obtains capsule of the present invention.
Pharmacology of the present invention and effect as follows:
The present invention choose Herba Pyrolae, Aspongopus, Radix Salviae Miltiorrhizae, Radix Notoginseng powder, Rhizoma Phragmitis, Concha Arcae (calcined), Lignum Santali Albi, Endoconcha Sepiae, Herba Dendrobii, Semen Arecae, the Rhizoma Anemarrhenae, Endothelium Corneum Gigeriae Galli, Radix Codonopsis, Retinervus Luffae Fructus, Radix Dipsaci, Semen Cuscutae, Folium Hibisci Mutabilis, Nidus Vespae, succinum, the Rhizoma Atractylodis Macrocephalae, Fructus Toosendan, Flos Inulae, Cortex Phellodendri, Flos Magnoliae, Fructus Xanthii, Herba Violae, Fructus Citri Sarcodactylis, Herba Cirsii, the Cortex Eucommiae, Radix Scrophulariae, Fructus Evodiae, Rhizoma Imperatae, Cortex Cinnamomi, Radix Bupleuri, Semen Armeniacae Amarum, Herba Epimedii totally 36 taste raw material of Chinese medicine make capsule.
Wherein Herba Pyrolae, wind-damp dispelling, bone and muscle strengthening, hemostasis.
Aspongopus: salty in the mouth, temperature.Return liver,spleen,kidney warp.There is regulating QI to relieve pain, effect that warming middle-JIAO is supporing yang.
Radix Salviae Miltiorrhizae, coronary artery dilating, increases myocardial flow; Expansion peripheral blood vessel, blood flow increases.
Radix Notoginseng powder: sweet in the mouth, micro-hardship, temperature.Return liver, stomach warp.There is effect of dissipating blood stasis hemostasis, subduing swelling and relieving pain.
Rhizoma Phragmitis, clearing away heat-fire, promoting the production of body fluid to quench thirst, relieving restlessness, preventing or arresting vomiting, diuresis.
Concha Arcae (calcined): salty in the mouth is flat.Return lung, stomach, Liver Channel.Can expectorant blood stasis dispelling, relieving gastric hyperacidity to alleviate stomachache.For pantothenic acid etc. of having a stomachache.
Lignum Santali Albi, acrid in the mouth, warm in nature, nontoxic.Enter spleen, stomach, lung meridian, regulate the flow of vital energy, stomach function regulating.
Endoconcha Sepiae: salty in the mouth, puckery, temperature.Return spleen, kidney channel.There is astringing to arrest bleeding, the effect of antacid.
Herba Dendrobii, reinforcing stomach reg fluid, nourishing YIN and clearing away heat.
Semen Arecae: bitter in the mouth, pungent, temperature.Return stomach, large intestine channel.There is killing insect and eliminating accumulation, sending down the abnormal ascending QI, the effects such as row water.
The Rhizoma Anemarrhenae, clearing away heat-fire, promotes the production of body fluid and moisturizes.
Endothelium Corneum Gigeriae Galli, can promote gastric secretion, improves gastric acidity and eupepsy.
Radix Codonopsis, invigorating the spleen and replenishing QI, spleen invigorating lung benefiting.
Retinervus Luffae Fructus, dredge the meridian passage, heat-clearing and toxic substances removing, inducing diuresis to remove edema, hemostasis.
Radix Dipsaci, invigorating the liver and kidney; Bone and muscle strengthening; Blood circulation regulating.
Semen Cuscutae, the kidney invigorating and essence nourishing, nourishing the liver to improve visual acuity.
Folium Hibisci Mutabilis: micro-pungent, cool; Return lung, Liver Channel, there is Qingfei Liangxue, effect of detumescence and apocenosis.
Nidus Vespae, dispels the wind, counteracting toxic substances, parasite killing, pain relieving, antiallergic.
Succinum: main resinous, volatile oil.Enter the heart, liver, small intestine meridian.Have tranquillizing the mind by relieving convulsion, dissipating blood stasis stops blooding, effect of relieving stranguria by diuresis.
The Rhizoma Atractylodis Macrocephalae, has invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis, antiabortive effect.
Fructus Toosendan, catharsis liver-heat, promoting the circulation of QI to relieve pain, have the function except damp and hot, clearing away liver-fire, pain relieving, parasite killing.
Flos Inulae: bitter in the mouth; Pungent; Salty; Tepor.Return lung; Stomach; Large intestine channel.There is the effect of antiasthmatic effect.
Cortex Phellodendri, bitter in the mouth, cold in nature.Heat-clearing and toxic substances removing, pathogenic fire purging dampness.
Flos Magnoliae, dispersing wind and cold, clearing the nasal passage.
Fructus Xanthii, loose wind dehumidifying, understand things pain-stopping.
Herba Violae has heat-clearing and toxic substances removing, and removing heat from blood is subsided a swelling, the effect of clearing away heat-damp and promoting diuresis.
Fructus Citri Sarcodactylis, liver-smoothing, qi-regulating, and stomach and alleviating pain.
Herba Cirsii, cooling blood for hemostasis, promoting blood circulation and detoxication.
The Cortex Eucommiae, tool invigorating the liver and kidney, bone and muscle strengthening, blood pressure lowering, many effects such as antiabortive.
Radix Scrophulariae, clearing away heat and cooling blood, removing toxic substances, eliminating stagnation sore-throat relieving, YIN nourishing.
Fructus Evodiae, dispersing cold for relieving pain, stopping nausea and vomiting by lowering the adverse flow of QI, supporing yang antidiarrheal.
Rhizoma Imperatae, cooling blood for hemostasis, heat-clearing and toxic substances removing.
Cortex Cinnamomi, has complement sun, warming the spleen and stomach, removing accumulated cold, effect of coronary circulation-promoting pain-relieving and antidiarrheal.
Radix Bupleuri, expelling pathogenic factors from the exterior expels the heat-evil, dispersing the stagnated live-QI to relieve the stagnation of QI, elevate a turnable ladder yang-energy.
Semen Armeniacae Amarum, relieving cough and asthma, loosening bowel to relieve constipation.
Herba Epimedii, kidney invigorating and YANG supporting, expelling wind and removing dampness.
All medicines share above, play effect of heat-clearing and toxic substances removing, drying dampness to eliminate phlegm, dredge the meridian passage, pathogenic fire purging relieving restlessness altogether, evident in efficacy to the unclean symptom of phlegm-damp resistance network type Patients with Cerebral Infarction speech, can treating both the principal and secondary aspects of a disease.
Detailed description of the invention
Embodiment 1
Each raw material of Chinese medicine is taken by following weight:
Herba Pyrolae 10, Aspongopus 6, Radix Salviae Miltiorrhizae 10, Radix Notoginseng powder 7, Rhizoma Phragmitis 12, Concha Arcae (calcined) 7, Lignum Santali Albi 12, Endoconcha Sepiae 12, Herba Dendrobii 10, Semen Arecae 15, the Rhizoma Anemarrhenae 15, Endothelium Corneum Gigeriae Galli 10, Radix Codonopsis 8, Retinervus Luffae Fructus 15, Radix Dipsaci 10, Semen Cuscutae 10, Folium Hibisci Mutabilis 10, Nidus Vespae 10, succinum 6, the Rhizoma Atractylodis Macrocephalae 8, Fructus Toosendan 5, Flos Inulae 7, Cortex Phellodendri 10, Flos Magnoliae 12, Fructus Xanthii 6, Herba Violae 6, Fructus Citri Sarcodactylis 12, Herba Cirsii 15, the Cortex Eucommiae 5, Radix Scrophulariae 8, Fructus Evodiae 10, Rhizoma Imperatae 9, Cortex Cinnamomi 9, Radix Bupleuri 10, Semen Armeniacae Amarum 8, Herba Epimedii 6.
Preparation method is as follows:
A chooses the Aspongopus after weighing, Radix Notoginseng powder, Concha Arcae (calcined), Endoconcha Sepiae, succinum, is ground into 120-200 order fine powder respectively, sieves, mixes, obtain standby material one.
B is by remaining 31 taste raw material of Chinese medicine mixing, and add 8 times of water gagings, soak 2 hours, heating decoction 1.5 hours, filters to obtain decoction liquor one and residue; Residue adds 8 times of water gagings again, and heating decoction 1 hour, filters to obtain decoction liquor two; Merge decoction liquor one and decoction liquor two, filter, be under the condition of 60 DEG C in temperature, concentrating under reduced pressure becomes relative density to be the thick paste of 1.2-1.3, cold drying, is ground into 120-200 order fine powder, obtains standby material two.
Standby material one is mixed homogeneously with standby material two by c, dries, sterilization, then is ground into 200 order fineness, incapsulates, obtains capsule of the present invention (0.3-0.5 gram /).
Comparative example 1
Each crude drug is taken by following weight:
Herba Pyrolae 10, Radix Notoginseng powder 7, Rhizoma Phragmitis 12, Concha Arcae (calcined) 7, Lignum Santali Albi 12, Endoconcha Sepiae 12, Herba Dendrobii 10, Semen Arecae 15, the Rhizoma Anemarrhenae 15, Endothelium Corneum Gigeriae Galli 10, Radix Codonopsis 8, Retinervus Luffae Fructus 15, Radix Dipsaci 10, Semen Cuscutae 10, Folium Hibisci Mutabilis 10, Nidus Vespae 10, succinum 6, the Rhizoma Atractylodis Macrocephalae 8, Fructus Toosendan 5, Flos Inulae 7, Cortex Phellodendri 10, Flos Magnoliae 12, Fructus Xanthii 6, Herba Violae 6, Fructus Citri Sarcodactylis 12, Herba Cirsii 15, the Cortex Eucommiae 5, Radix Scrophulariae 8, Fructus Evodiae 10, Rhizoma Imperatae 9, Cortex Cinnamomi 9, Radix Bupleuri 10, Semen Armeniacae Amarum 8, Herba Epimedii 6.
Preparation method is as follows:
A chooses the Radix Notoginseng powder after weighing, Concha Arcae (calcined), Endoconcha Sepiae, succinum, is ground into 120-200 order fine powder respectively, sieves, mixes, obtain standby material one.
B is by remaining 30 taste raw material of Chinese medicine mixing, and add 8 times of water gagings, soak 2 hours, heating decoction 1.5 hours, filters to obtain decoction liquor one and residue; Residue adds 8 times of water gagings again, and heating decoction 1 hour, filters to obtain decoction liquor two; Merge decoction liquor one and decoction liquor two, filter, be under the condition of 60 DEG C in temperature, concentrating under reduced pressure becomes relative density to be the thick paste of 1.2-1.3, cold drying, is ground into 120-200 order fine powder, obtains standby material two.
Standby material one is mixed homogeneously with standby material two by c, dries, sterilization, then is ground into 200 order fineness, incapsulates, obtains capsule of the present invention (0.3-0.5 gram /).
Comparative example 2
Each crude drug is taken by following weight:
Herba Pyrolae 10, Aspongopus 6, Radix Salviae Miltiorrhizae 10, Radix Notoginseng powder 7, Rhizoma Phragmitis 12, Concha Arcae (calcined) 7, Lignum Santali Albi 12, Endoconcha Sepiae 12, Herba Dendrobii 10, Semen Arecae 15, the Rhizoma Anemarrhenae 15, Endothelium Corneum Gigeriae Galli 10, Radix Codonopsis 8, Retinervus Luffae Fructus 15, Radix Dipsaci 10, Semen Cuscutae 10, Folium Hibisci Mutabilis 10, Nidus Vespae 10, succinum 6, the Rhizoma Atractylodis Macrocephalae 8, Fructus Toosendan 5, Cortex Phellodendri 10, Flos Magnoliae 12, Fructus Xanthii 6, Herba Violae 6, Fructus Citri Sarcodactylis 12, Herba Cirsii 15, the Cortex Eucommiae 5, Radix Scrophulariae 8, Fructus Evodiae 10, Rhizoma Imperatae 9, Cortex Cinnamomi 9, Radix Bupleuri 10, Semen Armeniacae Amarum 8, Herba Epimedii 6.
Preparation method is as follows:
A chooses the Aspongopus after weighing, Radix Notoginseng powder, Concha Arcae (calcined), Endoconcha Sepiae, succinum, is ground into 120-200 order fine powder respectively, sieves, mixes, obtain standby material one.
B is by remaining 30 taste raw material of Chinese medicine mixing, and add 8 times of water gagings, soak 2 hours, heating decoction 1.5 hours, filters to obtain decoction liquor one and residue; Residue adds 8 times of water gagings again, and heating decoction 1 hour, filters to obtain decoction liquor two; Merge decoction liquor one and decoction liquor two, filter, be under the condition of 60 DEG C in temperature, concentrating under reduced pressure becomes relative density to be the thick paste of 1.2-1.3, cold drying, is ground into 120-200 order fine powder, obtains standby material two.
Standby material one is mixed homogeneously with standby material two by c, dries, sterilization, then is ground into 200 order fineness, incapsulates, obtains capsule of the present invention (0.3-0.5 gram /).
Clinical data
(1) physical data
Choose ambiguous patient 200 example of phlegm-damp resistance network type cerebral infarction speech that in June, 2009, in December ,-2013 Neurology Department was accepted for medical treatment, all meet nineteen ninety-five the 4th national cerebrovascular academic conference Revised diagnostic criteria, and be diagnosed as cerebral infarction through head CT or MRI scanning, and MMSE is used to evaluate and test patient without dysnoesia.Be divided into four groups at random, treated one group of 50 example, treated two group of 50 example, treated three group of 50 example, matched group 50 example.Four groups of patients are through statistical analysis there was no significant difference (P>0.05) in sex, age, the course of disease etc., and data has comparability.
(2) Therapeutic Method
Matched group adopts the treatment of the routine recovery training method, treat one group adds with the obtained capsule of the embodiment of the present invention 1 on the routine recovery training method treatment basis, three times on the one, one time 3, one after each meal, within 10th, be 1 course for the treatment of, patients with mild takes 1-2 the course for the treatment of continuously, and severe patient takes 3 courses for the treatment of continuously.Treat two groups to add on the routine recovery training method treatment basis with the obtained capsule of comparative example 1 of the present invention.Treat three groups to add on the routine recovery training method treatment basis with the obtained capsule of comparative example 2 of the present invention.Treat two groups and treat one group with the method for administration for the treatment of three groups is same.
(3) efficacy assessment standard
Chinese aphasia check table is adopted to carry out evaluation score.This assessment method comprises nine contents: i.e. spontaneous talk, repetition, name, understanding, read, write, structure and visual space, utilization, calculating, total score 100 points.
Cure: scoring is 100 points;
Effective: to mark as being greater than 80 points;
Effective: to mark as 60-80 divides;
Invalid: scoring is less than 60 points.
(4) therapeutic effect
As following table 1.
Table 1
| Group | Cure | Effective | Effectively | Invalid | Total effective rate |
| Treat one group | 40 | 6 | 4 | 0 | 100％ |
| Treat two groups | 1 | 12 | 19 | 18 | 64％ |
| Treat three groups | 2 | 13 | 19 | 16 | 68％ |
| Matched group | 0 | 12 | 16 | 22 | 56％ |
As can be seen from Table 1, treat the cure rate of a group and total effective rate apparently higher than matched group, illustrate that treatment one group adds on the basis for the treatment of of control group that to treat phlegm-damp resistance network type cerebral infarction speech ambiguous patient with decoction of the present invention evident in efficacy, is worth further clinical expansion.
Claims (2)
1. the unclean Chinese medicine capsules for the treatment of phlegm-damp resistance network type Patients with Cerebral Infarction speech, it is characterized in that it is made by the raw material of Chinese medicine of following weight: Herba Pyrolae 10, Aspongopus 6, Radix Salviae Miltiorrhizae 10, Radix Notoginseng powder 7, Rhizoma Phragmitis 12, Concha Arcae (calcined) 7, Lignum Santali Albi 12, Endoconcha Sepiae 12, Herba Dendrobii 10, Semen Arecae 15, the Rhizoma Anemarrhenae 15, Endothelium Corneum Gigeriae Galli 10, Radix Codonopsis 8, Retinervus Luffae Fructus 15, Radix Dipsaci 10, Semen Cuscutae 10, Folium Hibisci Mutabilis 10, Nidus Vespae 10, succinum 6, the Rhizoma Atractylodis Macrocephalae 8, Fructus Toosendan 5, Flos Inulae 7, Cortex Phellodendri 10, Flos Magnoliae 12, Fructus Xanthii 6, Herba Violae 6, Fructus Citri Sarcodactylis 12, Herba Cirsii 15, the Cortex Eucommiae 5, Radix Scrophulariae 8, Fructus Evodiae 10, Rhizoma Imperatae 9, Cortex Cinnamomi 9, Radix Bupleuri 10, Semen Armeniacae Amarum 8, Herba Epimedii 6.
2. the preparation method of Chinese medicine capsules as claimed in claim 1, is characterized in that comprising the following steps:
A takes Herba Pyrolae, Aspongopus, Radix Salviae Miltiorrhizae, Radix Notoginseng powder, Rhizoma Phragmitis, Concha Arcae (calcined), Lignum Santali Albi, Endoconcha Sepiae, Herba Dendrobii, Semen Arecae, the Rhizoma Anemarrhenae, Endothelium Corneum Gigeriae Galli, Radix Codonopsis, Retinervus Luffae Fructus, Radix Dipsaci, Semen Cuscutae, Folium Hibisci Mutabilis, Nidus Vespae, succinum, the Rhizoma Atractylodis Macrocephalae, Fructus Toosendan, Flos Inulae, Cortex Phellodendri, Flos Magnoliae, Fructus Xanthii, Herba Violae, Fructus Citri Sarcodactylis, Herba Cirsii, the Cortex Eucommiae, Radix Scrophulariae, Fructus Evodiae, Rhizoma Imperatae, Cortex Cinnamomi, Radix Bupleuri, Semen Armeniacae Amarum, Herba Epimedii totally 36 taste raw material of Chinese medicine respectively according to above-mentioned weight proportion;
B chooses the Aspongopus after weighing, Radix Notoginseng powder, Concha Arcae (calcined), Endoconcha Sepiae, succinum, is ground into 120-200 order fine powder respectively, sieves, mixes, obtain standby material one;
C is by remaining 31 taste raw material of Chinese medicine mixing, and add 8 times of water gagings, soak 2 hours, heating decoction 1.5 hours, filters to obtain decoction liquor one and residue; Residue adds 8 times of water gagings again, and heating decoction 1 hour, filters to obtain decoction liquor two; Merge decoction liquor one and decoction liquor two, filter, be under the condition of 60 DEG C in temperature, concentrating under reduced pressure becomes relative density to be the thick paste of 1.2-1.3, cold drying, is ground into 120-200 order fine powder, obtains standby material two;
Standby material one is mixed homogeneously with standby material two by d, dries, sterilization, then is ground into 200 order fineness, incapsulates, obtains capsule of the present invention.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510711669.6A CN105194407A (en) | 2015-10-28 | 2015-10-28 | Traditional Chinese medicine capsules for treatment of verbal ambiguity of phlegm-dampness collateral-blocking type cerebral infarction patients and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510711669.6A CN105194407A (en) | 2015-10-28 | 2015-10-28 | Traditional Chinese medicine capsules for treatment of verbal ambiguity of phlegm-dampness collateral-blocking type cerebral infarction patients and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105194407A true CN105194407A (en) | 2015-12-30 |
Family
ID=54942591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510711669.6A Withdrawn CN105194407A (en) | 2015-10-28 | 2015-10-28 | Traditional Chinese medicine capsules for treatment of verbal ambiguity of phlegm-dampness collateral-blocking type cerebral infarction patients and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105194407A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103736029A (en) * | 2014-01-19 | 2014-04-23 | 王浦强 | Medicine for treating cerebral thrombosis and preparation method |
| CN103751477A (en) * | 2014-01-14 | 2014-04-30 | 郝连玉 | Traditional Chinese medicine composition for treating slurred speech of phlegm-damp blocking cerebral infarction patient |
| CN103933200A (en) * | 2014-01-14 | 2014-07-23 | 李承文 | Traditional Chinese medicine composition for treating apoplexy sequela |
| CN104338052A (en) * | 2014-09-29 | 2015-02-11 | 赵霞 | Formula of traditional Chinese medicine for treating cerebral thrombosis |
-
2015
- 2015-10-28 CN CN201510711669.6A patent/CN105194407A/en not_active Withdrawn
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103751477A (en) * | 2014-01-14 | 2014-04-30 | 郝连玉 | Traditional Chinese medicine composition for treating slurred speech of phlegm-damp blocking cerebral infarction patient |
| CN103933200A (en) * | 2014-01-14 | 2014-07-23 | 李承文 | Traditional Chinese medicine composition for treating apoplexy sequela |
| CN103736029A (en) * | 2014-01-19 | 2014-04-23 | 王浦强 | Medicine for treating cerebral thrombosis and preparation method |
| CN104338052A (en) * | 2014-09-29 | 2015-02-11 | 赵霞 | Formula of traditional Chinese medicine for treating cerebral thrombosis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103585299B (en) | Medicine for treating disc protrusion and bulge of lumbar vertebra and cervical vertebra | |
| CN101766775A (en) | Medicine for treating lumbar disc herniation and osteoproliferation | |
| CN103520413A (en) | Chinese medicament for treating asthma | |
| CN103083556B (en) | Traditional Chinese medicine for treating cervical spondylosis | |
| CN103736018A (en) | Medicine for treating gallstones and preparation method thereof | |
| CN102614390A (en) | Medicine for treating hypertension | |
| CN101112537A (en) | Chinese traditional medicine preparations for treating hyperosteogeny disease | |
| CN104784511A (en) | Medicine for treating coronary heart disease | |
| CN102631538B (en) | Traditional Chinese medicine for treating heart disease | |
| CN104491733A (en) | Application of traditional Chinese medicine preparation in preparation of medicines for treating anemia, deficiency of vital energy and debilitation | |
| CN103479947B (en) | The preparation method of control constipation medicine | |
| CN104225507A (en) | Chinese medicine for treating limb paralysis and pain caused by cerebral hemorrhage | |
| CN103705900A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN102225118A (en) | Blood-activating wind-dispelling liquid | |
| CN105664053A (en) | Traditional Chinese medicine composition for treating calluses on puncture of internal arteriovenous fistula of maintenance hemodialysis patient | |
| CN105456924A (en) | Traditional Chinese medicine preparation containing Folium Artemisiae Argyi and having functions of promoting circulation and removing stasis and preparation method thereof | |
| CN105233176A (en) | Traditional Chinese medicine decoction for treating periodontal disease | |
| CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
| CN105194407A (en) | Traditional Chinese medicine capsules for treatment of verbal ambiguity of phlegm-dampness collateral-blocking type cerebral infarction patients and preparation method thereof | |
| CN104758835B (en) | A kind of Chinese medicine being used for the treatment of cerebral infarction disease | |
| CN104873911A (en) | Traditional Chinese medicine for oral administration for adjunctively treating sepsis | |
| CN105169288A (en) | Traditional Chinese medicine decoction for treating unclear speech of phlegm-damp collateral accumulation type cerebral infarction patient | |
| CN103479949A (en) | Medicine for preventing and treating constipation | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN103638469B (en) | A kind of Chinese medicine for the treatment of coronary heart disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20151230 |